Follow
Kenneth Shinozuka
Kenneth Shinozuka
Verified email at psych.ox.ac.uk
Title
Cited by
Cited by
Year
Affixation of objects to garments
KF Shinozuka, M Mizuta
US Patent 9,345,433, 2016
472016
A curcumin analog reduces levels of the Alzheimer’s disease-associated amyloid-β protein by modulating AβPP processing and autophagy
Y Wan, Y Liang, F Liang, N Shen, K Shinozuka, JT Yu, C Ran, Q Quan, ...
Journal of Alzheimer's Disease 72 (3), 761-771, 2019
252019
Devices and methods for indoor geolocation
KF Shinozuka, M Mizuta
US Patent App. 14/703,792, 2016
252016
Sock for bed-departure detection
KF Shinozuka
US Patent 8,736,439, 2014
162014
Detection of changes from a seated or lying body position by sensing body angle
KF Shinozuka, M Mizuta
US Patent 9,468,399, 2016
52016
The museum of consciousness: interactive, audio-based exhibits for cultivating altered states of consciousness
CH Smith, K Shinozuka, A Zhao, M Ronen
Proceedings of EVA London 2021, 304-307, 2021
12021
Development of a novel task to assess peripheral awareness in the presence of foveal distractors
K Shinozuka, M McClure, S Alsewaidi, Y Du, C Fasano, A Spagna
PsyArXiv, 2024
2024
Psychedelic Therapy: A Primer for Primary Care Clinicians—Historical Perspective and Overview
BJ Tabaac, K Shinozuka, A Arenas, BD Beutler, K Cherian, VD Evans, ...
American Journal of Therapeutics 31 (2), e97-e103, 2024
2024
Psychedelic Therapy: A Primer for Primary Care Clinicians—3, 4-Methylenedioxy-methamphetamine (MDMA)
K Shinozuka, BJ Tabaac, A Arenas, BD Beutler, K Cherian, VD Evans, ...
American Journal of Therapeutics 31 (2), e141-e154, 2024
2024
Psychedelic Therapy: A Primer for Primary Care Clinicians—The Strengths, Weaknesses, Opportunities, and Threats of Psychedelic Therapeutics
OS Muir, K Shinozuka, BD Beutler, A Arenas, K Cherian, VD Evans, ...
American Journal of Therapeutics 31 (2), e178-e182, 2024
2024
Psychedelic Therapy: A Primer for Primary Care Clinicians—Ibogaine
K Cherian, K Shinozuka, BJ Tabaac, A Arenas, BD Beutler, VD Evans, ...
American Journal of Therapeutics 31 (2), e133-e140, 2024
2024
Psychedelic Therapy: A Primer for Primary Care Clinicians—Lysergic Acid Diethylamide (LSD)
BD Beutler, K Shinozuka, BJ Tabaac, A Arenas, K Cherian, VD Evans, ...
American Journal of Therapeutics 31 (2), e104-e111, 2024
2024
Psychedelic Therapy: A Primer for Primary Care Clinicians—Ketamine
VD Evans, A Arenas, K Shinozuka, BJ Tabaac, BD Beutler, K Cherian, ...
American Journal of Therapeutics 31 (2), e155-e177, 2024
2024
Psychedelic Therapy: A Primer for Primary Care Clinicians—N, N-Dimethyltryptamine and Ayahuasca
K Shinozuka, BJ Tabaac, A Arenas, BD Beutler, K Cherian, VD Evans, ...
American Journal of Therapeutics 31 (2), e112-e120, 2024
2024
Psychedelic Therapy: A Primer for Primary Care Clinicians—Psilocybin
BJ Tabaac, K Shinozuka, A Arenas, BD Beutler, K Cherian, VD Evans, ...
American Journal of Therapeutics 31 (2), e121-e132, 2024
2024
LSD flattens the hierarchy of directed information flow in fast whole-brain dynamics
K Shinozuka, P Tewarie, A Luppi, C Lynn, L Roseman, ...
bioRxiv, 2024.04. 25.591130, 2024
2024
The Hierarchy of Psychedelic Effects: Three Systematic Reviews and Meta-Analyses
K Shinozuka, K Jerotic, P Mediano, AT Zhao, KH Preller, R Carhart-Harris, ...
bioRxiv, 2023.10. 06.561183, 2023
2023
Foot Pressure-Sensor System for Tracking Safety and Health
K Shinozuka
Journal of Robotics and Mechatronics 26 (1), 116-119, 2014
2014
The system can't perform the operation now. Try again later.
Articles 1–18